ARTICLE | Company News
Oxford BioMedica management update
June 10, 2013 7:00 AM UTC
Oxford BioMedica plc (LSE:OXB), Oxford, U.K. Business: Cancer, Gene/Cell therapy, Neurology Departing: Stuart Naylor as CSO and a director Hired: Madhu Davies, an Oxford BioMedica consultant, as CMO, ...